Clinical Trials Logo

Clinical Trial Summary

This study uses new methods called "genome sequencing" that allow the investigators to study part or all of a person's genome. The genome is the collection of all of a person's genes. Genes carry the instructions that our bodies need to develop and function. Genes are passed on from one generation to the next. Genome sequencing can study all of a person's genome (whole genome sequencing) or just parts of their genome (whole exome sequencing). In the study, the investigators refer to all these research methods as 'genome sequencing'. Genome sequencing typically shows a large number of gene changes, known as "variants." Some (but not all) of these genetic variants may be linked to increased risks of diseases other than cancer.

The purpose of this study is to learn what kinds of genetic variants the patient wants to learn about from their genome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01692223
Study type Observational
Source Memorial Sloan Kettering Cancer Center
Contact
Status Completed
Phase
Start date September 2012
Completion date August 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05162846 - Methods for Increasing Genetic Testing Uptake in Michigan N/A